EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

VMA21 deficiency leads to autophagic dysregulation and altered vesicle trafficking in X-linked myopathy with excessive autophagy

Christian A Suarez, Sara K Pittman, Michio Inoue, Eileen M Lynch, Andrew Moran, Angèle N Merlet, Emmanuelle Lacenne, Teresinha Evangelista, Conrad C Weihl

Acta Neuropathologica · 2026

DOI: 10.1007/s00401-026-03044-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, 2026. Verfasst von Christian A Suarez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Washington University School of Medicine, St. Louis, MO, 63110, USA. Hauptthemen laut MEDLINE: Autophagy, Muscular Diseases, Vacuolar Proton-Translocating ATPases, Genetic Diseases, X-Linked. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

X-Linked myopathy with excessive autophagy (XMEA) is a rare vacuolar myopathy caused by mutations in Vma21, an assembly chaperone required for vacuolar H⁺–ATPase (V-ATPase) function. However, the mechanisms linking Vma21 deficiency to progressive muscle pathology remain poorly understood, in part due to the lack of suitable animal models. To address this gap, we generated conditional Vma21 knockout mouse models to investigate the consequences of Vma21 loss in striated muscle. Combined deletion of Vma21 in skeletal and cardiac muscle resulted in early lethality driven by severe cardiomyopathy associated with autophagic dysregulation, preceding the development of skeletal muscle pathology. In contrast, inducible skeletal muscle-specific deletion of Vma21 produced progressive muscle weakness and myopathy characterized by centralized nuclei, fiber splitting, and increased fiber size variability. Affected skeletal muscle also recapitulated defining pathological hallmarks of XMEA, including basal lamina reduplication and autophagic vacuoles with sarcolemmal features (AVSFs). Ultrastructural analysis revealed membrane-bound vacuoles containing partially undegraded material that frequently accumulated at the subsarcolemmal region, together with clusters of vesicular structures. Notably, mutant muscle exhibited increased staining for the late endosomal/exosomal marker CD63, which strongly colocalized with the complement membrane attack complex C5b-9. A similar increase in CD63 staining and its colocalization with C5b-9 were observed in skeletal muscle biopsies from patients with XMEA. Together, these models faithfully recapitulate key pathological features of XMEA and identify the accumulation of CD63-positive structures and their colocalization with C5b-9 as previously unrecognized features of Vma21-deficient skeletal muscle, implicating altered vesicle trafficking in XMEA pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyMuscular DiseasesVacuolar Proton-Translocating ATPasesGenetic Diseases, X-LinkedAnimalsMuscle, SkeletalMice, KnockoutDisease Models, AnimalMiceHumansMyocardium

Stichwörter der Autor:innen

AutophagyMembrane attack complexVMA21Vacuolar myopathyVesicle traffickingXMEA

Substanzen

Vacuolar Proton-Translocating ATPasesVMA21 protein, human

Autor:innen und Institutionen

  • Department of Neurology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Department of Clinical Physiology and Exercice, Myology Unit, Reference Center for Neuromuscular Diseases, Euro-NMD, University Hospital of Saint-Etienne, Saint-Priest-en-Jarez, France.
  • Interuniversity Laboratory of Human Movement Biology, Jean-Monnet University, Saint-Etienne, France.
  • Functional Unit of Neuromuscular Pathology, Department of Neuropathology, Myology Institute, Pitié-Salpêtrière Hospital, Assistance Publique Des Hôpitaux de Paris, Sorbonne University, Paris, France.
  • Department of Neurology, Washington University School of Medicine, St. Louis, MO, 63110, USA. weihlc@wustl.edu.
  • Department of Neurology, Washington University School of Medicine, WashU Jeffrey T. Fort Neuroscience Research Building, Room 8170, 4370 Duncan Avenue, St. Louis, MO, 63110, USA. weihlc@wustl.edu.

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Suarez, C. A., Pittman, S. K., Inoue, M., Lynch, E. M., Moran, A., Merlet, A. N., Lacenne, E., Evangelista, T., & Weihl, C. C. (2026). VMA21 deficiency leads to autophagic dysregulation and altered vesicle trafficking in X-linked myopathy with excessive autophagy. Acta Neuropathologica. https://doi.org/10.1007/s00401-026-03044-z

Vancouver

Suarez CA, Pittman SK, Inoue M, Lynch EM, Moran A, Merlet AN, et al. VMA21 deficiency leads to autophagic dysregulation and altered vesicle trafficking in X-linked myopathy with excessive autophagy. Acta Neuropathologica. 2026. doi:10.1007/s00401-026-03044-z

BibTeX
@article{Suarez2026,
  author = {Suarez, Christian A and Pittman, Sara K and Inoue, Michio and Lynch, Eileen M and Moran, Andrew and Merlet, Angèle N and Lacenne, Emmanuelle and Evangelista, Teresinha and Weihl, Conrad C},
  title = {VMA21 deficiency leads to autophagic dysregulation and altered vesicle trafficking in X-linked myopathy with excessive autophagy},
  journal = {Acta Neuropathologica},
  year = {2026},
  doi = {10.1007/s00401-026-03044-z}
}
Kostenlos starten →